CopyFind
TANAKAN 40 mg/ml, solution buvable

TANAKAN 40 mg/ml, solution buvable

Analogs of TANAKAN 40 mg/ml, solution buvable

Find cheaper analogs and generic equivalents for TANAKAN 40 mg/ml, solution buvable.

Ingredients

सक्रिय अवयव: ginkgo


उत्पाद अवलोकन

About TANAKAN 40 mg/ml, solution buvable

TANAKAN 40 mg/ml, solution buvable is a pharmaceutical product formulated as an oral solution. This medicine is designed for administration by mouth and is typically used in clinical settings to address specific vascular or cognitive symptoms. It is essential to follow the dosage instructions provided by a healthcare professional or those outlined in the official package insert to ensure safe and effective use. As with all medicinal products, this solution should be stored in a cool, dry place away from the reach of children. Patients should consult their physician or pharmacist before starting treatment to confirm that this medication is appropriate for their specific health profile and to discuss any potential interactions with other substances.

Key Benefits & Uses

  • Provides a standardized oral solution for consistent dosing.
  • Used for the management of specific cognitive and vascular conditions.
  • Formulated for convenient administration in liquid form.

Active Ingredient & Action

The active ingredient in TANAKAN 40 mg/ml, solution buvable is an extract known as extrait sec raffiné et quantifié de feuille de ginkgo. This standardized extract is processed to ensure a precise concentration of active components, which are intended to support vascular health and peripheral circulation.

Important Notes

This product is a medicine and should be used strictly according to medical advice. Do not exceed the recommended daily dose. If symptoms persist or worsen, seek medical attention immediately. Always check the expiration date before use.

Find in Pharmacies

Compare local prices and distance for TANAKAN 40 mg/ml, solution buvable.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.